Lymphatix Oy acquired by Ark Therapeutics Group plc
|
|
|
|
|
vascular endothelial growth factor genes known as VEGF-D and VEGF-C for developing gene-based medicines in the angiogenesis and lymphangiogenesis areas | |
Korean Distributor : ??? |
Products information :
|
|
|
|
|
|
|
|
|
|